Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the CNGB1 gene.
Features include always present findings: Bone spicule pigmentation of the retina, Nyctalopia, Peripheral visual field loss, and Rod-cone dystrophy and others; and sometimes findings: Macular degeneration.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 1 | Bone spicule pigmentation of the retina |
CNGB1 encodes cyclic nucleotide gated channel subunit beta 1 (1,251 aa). Pore-forming subunit of the rod cyclic nucleotide-gated channel. Mediates rod photoresponses at dim light converting transient changes in intracellular cGMP levels into electrical signals. Highest expression in Brain Hypothalamus (6.1 TPM) and Brain Cortex (3.1 TPM).
Retinitis pigmentosa 45 is associated with mutations in the CNGB1 gene on chromosome 16.
The CNGB1 protein participates in VxPx-containing ciliary membrane proteins and cGMP:CNG transports Na+ and Ca2+ into the rod outer segment pathways.
CNGB1 is classified as a druggable target (Druggable Genome, Ion Channel, and Transporter categories) with score 26.1.
Genetic testing for CNGB1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 45 has been reported in the published literature.
Phenotype severity distribution: 5 always present features.
No clinical trials have been registered for retinitis pigmentosa 45.
108 publications have been identified in PubMed for retinitis pigmentosa 45. Research spans Basic Science / Preclinical (24%), Case Report / Case Series (19%), and Clinical Trial Publication (19%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 26 | 24% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:56 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Eyes
1 |
Macular degeneration |
Age of onset: childhood.
21 |
19% |
Clinical study results | 21 | 19% |
Disease patterns and progression | 17 | 16% |
New treatment approaches | 12 | 11% |
Testing and diagnosis research | 5 | 5% |
Research summaries | 5 | 5% |
Other research | 1 | 1% |
Taha I (2026). [PMID: 41851861](https://pubmed.ncbi.nlm.nih.gov/41851861/). *BMC Ophthalmol*. [Epidemiology / Natural History]
Kadyshev VV (2026). [PMID: 41847811](https://pubmed.ncbi.nlm.nih.gov/41847811/). *Vestn Oftalmol*. [Epidemiology / Natural History]
Marsh K (2026). [PMID: 41697461](https://pubmed.ncbi.nlm.nih.gov/41697461/). *PharmacoEconomics - open*. [Diagnostic / Biomarker]
Al-Moujahed A (2026). [PMID: 41891913](https://pubmed.ncbi.nlm.nih.gov/41891913/). *Ophthalmic Surg Lasers Imaging Retina*. [Epidemiology / Natural History]
Charng J (2026). [PMID: 41552664](https://pubmed.ncbi.nlm.nih.gov/41552664/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Sung JY (2026). [PMID: 41341794](https://pubmed.ncbi.nlm.nih.gov/41341794/). *Ophthalmology science*. [Epidemiology / Natural History]
Li S (2026). [PMID: 41428313](https://pubmed.ncbi.nlm.nih.gov/41428313/). *Ophthalmology and therapy*. [Basic Science / Preclinical]
Papp KM (2026). [PMID: 41547546](https://pubmed.ncbi.nlm.nih.gov/41547546/). *Canadian journal of ophthalmology. Journal canadien d'ophtalmologie*. [Clinical Trial Publication]
Powell J (2026). [PMID: 41612341](https://pubmed.ncbi.nlm.nih.gov/41612341/). *Journal of neuroengineering and rehabilitation*. [Case Report / Case Series]
Stacks DA (2026). [PMID: 41292168](https://pubmed.ncbi.nlm.nih.gov/41292168/). *J Physiol*. [Basic Science / Preclinical]